A novel anti-IL-33 antibody recognizes an epitope FVLHN of IL-33 and has a therapeutic effect on inflammatory diseases

Thrombin cleaves IL‐33 and modulates IL‐33‐activated allergic lung inflammation

(2022) Yuying Huang et al.   ALLERGY

Emerging Functions of IL-33 in Homeostasis and Immunity

(2022) Gaelen K. Dwyer et al.   Annual Review of Immunology

Involvement of Il-33 in the Pathogenesis and Prognosis of Major Respiratory Viral Infections: Future Perspectives for Personalized Therapy

(2022) Giuseppe Murdaca et al.   Biomedicines

Emerging Effects of IL-33 on COVID-19

(2022) Yuan Gao et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

IL-33-induced metabolic reprogramming controls the differentiation of alternatively activated macrophages and the resolution of inflammation

(2021) Maria Faas et al.   IMMUNITY

Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma

(2021) Michael E. Wechsler et al.   NEW ENGLAND JOURNAL OF MEDICINE

Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19

(2020) Ahmet Kursat Azkur et al.   ALLERGY

IL-25/IL-33/TSLP contributes to idiopathic pulmonary fibrosis: Do alveolar epithelial cells and (myo)fibroblasts matter?

(2020) Xuefeng Xu et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives

(2020) Hilal Ahmed Parray et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Epithelial-Mesenchymal Transition in Asthma Airway Remodeling Is Regulated by the IL-33/CD146 Axis

(2020) Zhixiao Sun et al.   Frontiers in Immunology

Environmental exposures and mechanisms in allergy and asthma development

(2019) Liza Bronner Murrison et al.   JOURNAL OF CLINICAL INVESTIGATION

Economic burden of food allergy- A systematic review

(2019) Lucy A. Bilaver et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Characterization and allergic role of IL-33-induced neutrophil polarization

(2018) Bo Sun et al.   Cellular & Molecular Immunology

Asthma

(2018) Alberto Papi et al.   LANCET

Kinetics of the accumulation of group 2 innate lymphoid cells in IL-33-induced and IL-25-induced murine models of asthma: a potential role for the chemokine CXCL16

(2018) Yan Li et al.   Cellular & Molecular Immunology

Berberine suppresses IL-33-induced inflammatory responses in mast cells by inactivating NF-κB and p38 signaling

(2018) Weihua Li et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family

(2017) Corinne Cayrol et al.   IMMUNOLOGICAL REVIEWS

The ω-carboxyl group of 7-ketocholesteryl-9-carboxynonanoate mediates the binding of oxLDL to CD36 receptor and enhances caveolin-1 expression in macrophages

(2017) Jingda Li et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Advances in asthma in 2016: Designing individualized approaches to management

(2017) William C. Anderson et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Targeting the IL-33/IL-13 Axis for Respiratory Viral Infections

(2016) Chantal Donovan et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Isolation of Mature (Peritoneum-Derived) Mast Cells and Immature (Bone Marrow-Derived) Mast Cell Precursors from Mice

(2016) Steffen K. Meurer et al.   PLoS One

The role of IL-33/ST2L signals in the immune cells

(2015) Jingli Lu et al.   IMMUNOLOGY LETTERS

IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy

(2014) Corinne Cayrol et al.   CURRENT OPINION IN IMMUNOLOGY

Interleukin 33: a switch-hitting cytokine

(2014) Daniel O Villarreal et al.   CURRENT OPINION IN IMMUNOLOGY

Increased serum levels of interleukin 33 in patients with atopic dermatitis

(2014) Risa Tamagawa-Mineoka et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells

(2014) E. Lefrancais et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Affinity Enhancement of Antibodies: How Low-Affinity Antibodies Produced Early in Immune Responses Are Followed by High-Affinity Antibodies Later and in Memory B-Cell Responses

(2014) H. N. Eisen   Cancer Immunology Research

IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G

(2012) E. Lefrancais et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity

(2011) Ya-Jen Chang et al.   NATURE IMMUNOLOGY

IL-33 is a crucial amplifier of innate rather than acquired immunity

(2010) K. Oboki et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma

(2009) Xiaojin Liu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Increased Expression of IL-33 in Severe Asthma: Evidence of Expression by Airway Smooth Muscle Cells

(2009) D. Prefontaine et al.   JOURNAL OF IMMUNOLOGY

Structure of IL-33 and Its Interaction with the ST2 and IL-1RAcP Receptors—Insight into Heterotrimeric IL-1 Signaling Complexes

(2009) Andreas Lingel et al.   STRUCTURE

IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK Cells

(2008) M. D. Smithgall et al.   INTERNATIONAL IMMUNOLOGY